Christiana Stamoulis Incyte Corp (INCY) insider trading activity

Christiana Stamoulis is EVP & Chief Financial Officer of INCYTE CORP. Currently has a direct ownership of 129,093 shares of INCY, which is worth approximately $7.82 Million. The most recent transaction as insider was on Apr 01, 2025, when has been sold 37,568 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 129K

35.61% 3M change

43.46% 12M change

Total Value Held $7.82 Million

Christiana Stamoulis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2025	BUY Grant, award, or other acquisition	-	37,568 Added 22.54%	129,093 Common Stock
Jan 15 2025	SELL Payment of exercise price or tax liability	$266,073 $72.46 p/Share	3,672 Reduced 3.86%	91,525 Common Stock
Jul 15 2024	SELL Payment of exercise price or tax liability	$60,909 $64.25 p/Share	948 Reduced 0.99%	95,197 Common Stock
Jul 15 2024	BUY Grant, award, or other acquisition	-	12,572 Added 11.56%	96,145 Common Stock
Jul 02 2024	SELL Payment of exercise price or tax liability	$405,467 $59.02 p/Share	6,870 Reduced 7.6%	83,573 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	7,377 Added 7.58%	89,983 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$22,384 $57.84 p/Share	387 Reduced 0.47%	82,606 Common Stock
Jul 14 2023	BUY Grant, award, or other acquisition	-	12,246 Added 12.86%	82,993 Common Stock
Jul 03 2023	SELL Payment of exercise price or tax liability	$377,011 $62.08 p/Share	6,073 Reduced 7.91%	70,747 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$94,414 $80.08 p/Share	1,179 Reduced 1.52%	76,460 Common Stock
Jan 20 2023	BUY Grant, award, or other acquisition	-	4,980 Added 6.03%	77,639 Common Stock
Jul 05 2022	SELL Payment of exercise price or tax liability	$89,077 $79.25 p/Share	1,124 Reduced 1.52%	72,659 Common Stock
Jul 02 2022	BUY Grant, award, or other acquisition	-	17,317 Added 19.01%	73,783 Common Stock
Feb 11 2022	SELL Payment of exercise price or tax liability	$78,577 $66.76 p/Share	1,177 Reduced 2.05%	56,285 Common Stock
Jan 01 2022	BUY Grant, award, or other acquisition	-	14,463 Added 20.11%	57,462 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	-	2,734 Added 5.98%	42,999 Common Stock
Jul 02 2021	SELL Payment of exercise price or tax liability	-	516 Reduced 1.27%	40,265 Common Stock
Jul 02 2021	BUY Grant, award, or other acquisition	-	7,853 Added 16.15%	40,781 Common Stock
Feb 11 2021	SELL Payment of exercise price or tax liability	$102,838 $84.99 p/Share	1,210 Reduced 3.58%	32,611 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	11,522 Added 25.41%	33,821 Common Stock
Nov 16 2020	BUY Grant, award, or other acquisition	-	1,232 Added 5.24%	22,299 Common Stock

Also insider at

HOLX

HOLOGIC INC Healthcare

Director